Loyal Gets First FDA OK for Dog Lifespan Drug FDA backs Loyal on Apr 11, 2026 as the first canine lifespan drug; addresses roughly 90m US dogs and a $136.8bn pet market (APPA 2022).

Loyal Gets First FDA OK for Dog Lifespan Drug: FDA backs Loyal on Apr 11, 2026 as the first canine lifespan drug; addresses roughly 90m US dogs and a $136.8bn pet market (APPA 2022). 👈 Read full analysis #DogHealth #PetCare #FDAApproval #LifespanDrug #VeterinaryMedicine